These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34288098)
1. In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs disease. Almanasra A; Havranek B; Islam SM Proteins; 2021 Nov; 89(11):1587-1601. PubMed ID: 34288098 [TBL] [Abstract][Full Text] [Related]
2. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. Lemieux MJ; Mark BL; Cherney MM; Withers SG; Mahuran DJ; James MN J Mol Biol; 2006 Jun; 359(4):913-29. PubMed ID: 16698036 [TBL] [Abstract][Full Text] [Related]
3. In silico screening and molecular dynamics simulation of deleterious PAH mutations responsible for phenylketonuria genetic disorder. Lopez A; Havranek B; Papadantonakis GA; Islam SM Proteins; 2021 Jun; 89(6):683-696. PubMed ID: 33491267 [TBL] [Abstract][Full Text] [Related]
4. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease. Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum. Ibrahim DMA; Ali OSM; Nasr H; Fateen E; AbdelAleem A Orphanet J Rare Dis; 2023 Mar; 18(1):52. PubMed ID: 36907859 [TBL] [Abstract][Full Text] [Related]
6. Three novel mutations in Iranian patients with Tay-Sachs disease. Jamali S; Eskandari N; Aryani O; Salehpour S; Zaman T; Kamalidehghan B; Houshmand M Iran Biomed J; 2014; 18(2):114-9. PubMed ID: 24518553 [TBL] [Abstract][Full Text] [Related]
7. Novel HEXA variants in Korean children with Tay-Sachs disease with regression of neurodevelopment from infancy. Park JH; Ko JM; Kim MS; Kim MJ; Seong MW; Yoo T; Lim BC; Chae JH Mol Genet Genomic Med; 2021 Jun; 9(6):e1677. PubMed ID: 33811753 [TBL] [Abstract][Full Text] [Related]
9. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652 [TBL] [Abstract][Full Text] [Related]
16. Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease. Matsuoka K; Tsuji D; Aikawa S; Matsuzawa F; Sakuraba H; Itoh K Mol Ther; 2010 Aug; 18(8):1519-26. PubMed ID: 20571546 [TBL] [Abstract][Full Text] [Related]
17. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis]. Tsuji D Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522 [TBL] [Abstract][Full Text] [Related]
19. Identification of deletion-duplication in HEXA gene in five children with Tay-Sachs disease from India. Sheth J; Mistri M; Mahadevan L; Mehta S; Solanki D; Kamate M; Sheth F BMC Med Genet; 2018 Jul; 19(1):109. PubMed ID: 29973161 [TBL] [Abstract][Full Text] [Related]
20. Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA/HexB expressing lentiviral vector. Beegle J; Hendrix K; Maciel H; Nolta JA; Anderson JS J Gene Med; 2020 Sep; 22(9):e3205. PubMed ID: 32335981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]